Association of citalopram with congenital anomalies: A meta-analysis

OBJECTIVE: The antenatal use of citalopram, a widely prescribed selective serotonin reuptake inhibitor, has been suspected to be associated with congenital, particularly cardiac, anomalies. This study aimed to prove the association between citalopram use and congenital anomalies. METHODS: We searche...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hyun-Hye, Ahn, Ki Hoon, Hong, Soon-Cheol, Kwon, Bo Yong, Lee, Eun Hee, Lee, Ji-Sung, Oh, Min-Jeong, Kim, Hai-Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364096/
https://www.ncbi.nlm.nih.gov/pubmed/28344955
http://dx.doi.org/10.5468/ogs.2017.60.2.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364096/
https://www.ncbi.nlm.nih.gov/pubmed/28344955
http://dx.doi.org/10.5468/ogs.2017.60.2.145

Ejemplares similares